MAPT and Alzheimer disease: Reported causes that increase the risk of AD with the carrying apoE4 isoform include an imbalance of Aβ equilibrium (balance of production and clearance) (51, 52), production of neurotoxic apoE peptide fragments (53), exacerbation of tau protein phosphorylation and aggregation (54), and neurodegeneration (55).